WordNet

a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
how long something has existed; "it was replaced because of its age"
a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
begin to seem older; get older; "The death of his wife caused him to age fast"
make older; "The death of his child aged him tremendously"
a medicine that inhibits cholinesterase by combining with it and so has a cholinergic effect

PrepTutorEJDIC

『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 新生児および幼児における神経筋接合部障害 neuromuscular junction disorders in newborns and infants
2. 眼筋型重症筋無力症 ocular myasthenia gravis
3. 小児における外眼筋に影響するミオパチー myopathies affecting the extraocular muscles in children
4. 小児および思春期における注意欠陥多動性障害治療薬の薬理学 pharmacology of drugs used to treat attention deficit hyperactivity disorder in children and adolescents
5. 前立腺癌の危険因子 risk factors for prostate cancer

Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives.

Wang Y1, Sun Y1, Guo Y1, Wang Z1, Huang L1, Li X1.
Journal of enzyme inhibition and medicinal chemistry.J Enzyme Inhib Med Chem.2016 Jun;31(3):389-97. doi: 10.3109/14756366.2015.1024675. Epub 2015 Mar 23.
Because of the complexity of Alzheimer's disease (AD), the multi-target-directed ligand (MTDL) strategy is expected to provide superior effects for the treatment of AD, instead of the classic one-drug-one-target strategy. In this context, we focused on the design, synthesis and evaluation of homoiso
PMID 25798687

Influence of Educational Attainment on Cognition-Based Intervention Programs for Persons with Mild Alzheimer's Disease.

Contador I1, Fernández-Calvo B2, Ramos F3, Olazarán J4.
Journal of the International Neuropsychological Society : JINS.J Int Neuropsychol Soc.2016 Mar 15:1-6. [Epub ahead of print]
OBJECTIVES: This research retrospectively analyzed the effect of education on cognitive interventions carried out in patients with mild Alzheimer's disease (AD).METHODS: The total sample consisted of 75 patients with mild AD receiving treatment with cholinesterase inhibitors. The participants were d
PMID 26976668

Siddiqi N1, Harrison JK, Clegg A, Teale EA, Young J, Taylor J, Simpkins SA.
The Cochrane database of systematic reviews.Cochrane Database Syst Rev.2016 Mar 11;3:CD005563. [Epub ahead of print]
BACKGROUND: Delirium is a common mental disorder, which is distressing and has serious adverse outcomes in hospitalised patients. Prevention of delirium is desirable from the perspective of patients and carers, and healthcare providers. It is currently unclear, however, whether interventions for pre
PMID 26967259

Behavioral Changes and Cholinesterase Activity of Rats Acutely Treated With Propoxur

Thiesen Flavia Valladao,Barros Helena M.T.,Tannhauser Mario [他],TANNHAUSER Semiramis L.
The Japanese journal of pharmacology 79(1), 25-31, 1999-01-00
… The time course of the effects of an oral dose of the anticholinesterase agent propoxur (8.3 mg/kg) was determined on behaviors displayed in the open-field and during an active avoidance task by rats and on blood and brain cholinesterase activity. …
NAID 10008194029